Interestingly, we observed a reduction in p-c-Jun (S63) and total c-Jun levels following treatment with pan-SFK inhibitors in both human (Figure 2A) and mouse (Figure 2B) breast cancer cells. The gene discussed is JUN; the disease is breast carcinoma.